Healthcare Sector Stocks
The Healthcare sector has a total of 1064 stocks, with a combined market cap of $8.27 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.20.
Market Cap
8.27T
Revenue
4.59T
Profits
200.81B
PE Ratio
41.20
Profit Margin
4.38%
Dividend Yield
0.43%
1064 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 905.12B | 2.54% | 1,831,722 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 552.31B | 2.31% | 3,036,611 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 366.43B | -0.22% | 1,860,787 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 364.50B | 1.26% | 4,566,991 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 287.98B | 0.78% | 873,299 | 60.44B |
| 6 | NVS | Novartis AG | 282.72B | 0.88% | 651,189 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 280.79B | 1.17% | 2,401,198 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 207.87B | -0.38% | 6,827,946 | 50.57B |
| 9 | AMGN | Amgen Inc. | 180.29B | -0.67% | 857,516 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 165.44B | -3.07% | 1,166,972 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 165.00B | -1.51% | 2,944,477 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 153.16B | 0.13% | 946,388 | 10.58B |
| 13 | PFE | Pfizer Inc. | 147.22B | -0.15% | 11,988,275 | 63.32B |
| 14 | ABT | Abbott Laboratories | 145.74B | -0.81% | 6,504,529 | 45.13B |
| 15 | CVS | CVS Health Corporation | 124.02B | 2.15% | 6,680,879 | 405.62B |
| 16 | DHR | Danaher Corporation | 117.02B | -0.56% | 3,332,673 | 24.78B |
| 17 | SYK | Stryker Corporation | 115.45B | 2.28% | 1,648,938 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 115.25B | -0.02% | 2,349,284 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 114.13B | 0.31% | 523,297 | 12.22B |
| 20 | SNY | Sanofi | 103.23B | -0.66% | 1,022,303 | 54.60B |
| 21 | GSK | GSK plc | 101.98B | 0.26% | 1,923,478 | 43.29B |
| 22 | MDT | Medtronic plc | 97.90B | -0.74% | 5,054,142 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 95.30B | -0.02% | 706,779 | 76.39B |
| 24 | MCK | McKesson Corporation | 88.61B | 0.33% | 452,292 | 403.43B |
| 25 | ELV | Elevance Health, Inc. | 86.29B | 1.03% | 871,582 | 200.42B |
| 26 | BSX | Boston Scientific Corporation | 79.80B | -0.76% | 6,593,584 | 20.61B |
| 27 | CI | The Cigna Group | 79.11B | 0.19% | 1,015,673 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 72.78B | -1.11% | 323,602 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 51.96B | 0.18% | 2,243,518 | 28.48B |
| 30 | ARGX | argenx SE | 50.91B | -1.85% | 234,731 | 4.74B |
| 31 | COR | Cencora, Inc. | 50.47B | -0.58% | 986,298 | 328.68B |
| 32 | MDLN | Medline Inc. | 50.25B | -0.78% | 3,891,751 | 29.14B |
| 33 | EW | Edwards Lifesciences Corporation | 46.74B | 1.81% | 2,235,607 | 6.30B |
| 34 | CAH | Cardinal Health, Inc. | 43.42B | 1.55% | 1,148,409 | 250.74B |
| 35 | TEVA | Teva Pharmaceutical Industries Limited | 42.12B | 1.01% | 1,872,628 | 17.35B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 41.64B | -1.14% | 222,614 | 4.45B |
| 37 | HLN | Haleon plc | 40.18B | -0.99% | 5,613,795 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 39.60B | -2.58% | 2,013,733 | 22.23B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.06B | 0.17% | 325,926 | 4.29B |
| 40 | HUM | Humana Inc. | 36.82B | 3.84% | 1,603,470 | 137.20B |
| 41 | ONC | BeOne Medicines AG | 35.33B | 0.86% | 75,639 | 5.70B |
| 42 | WAT | Waters Corporation | 32.89B | -4.89% | 461,538 | 3.77B |
| 43 | A | Agilent Technologies, Inc. | 31.94B | 0.11% | 853,647 | 7.07B |
| 44 | ZTS | Zoetis Inc. | 31.58B | -2.09% | 6,024,060 | 9.53B |
| 45 | RVMD | Revolution Medicines, Inc. | 31.54B | 1.80% | 820,331 | - |
| 46 | ALC | Alcon Inc. | 31.27B | -0.55% | 912,335 | 10.63B |
| 47 | RPRX | Royalty Pharma plc | 30.17B | 1.35% | 1,073,841 | 2.44B |
| 48 | BIIB | Biogen Inc. | 29.51B | 0.28% | 338,266 | 9.94B |
| 49 | RMD | ResMed Inc. | 29.34B | -0.76% | 367,207 | 5.54B |
| 50 | CNC | Centene Corporation | 29.07B | -0.74% | 2,802,210 | 178.33B |
| 51 | IQV | IQVIA Holdings Inc. | 28.71B | -1.75% | 683,356 | 16.63B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 28.29B | -0.14% | 1,924,697 | 20.98B |
| 53 | NTRA | Natera, Inc. | 28.07B | -4.02% | 624,326 | 2.50B |
| 54 | INSM | Insmed Incorporated | 25.69B | 2.16% | 4,279,794 | 819.56M |
| 55 | VEEV | Veeva Systems Inc. | 25.39B | -2.49% | 1,069,412 | 3.20B |
| 56 | PHG | Koninklijke Philips N.V. | 24.70B | -5.16% | 1,019,269 | 20.34B |
| 57 | UTHR | United Therapeutics Corporation | 24.55B | -0.59% | 103,701 | 3.17B |
| 58 | BNTX | BioNTech SE | 23.32B | -1.53% | 528,403 | 3.23B |
| 59 | DXCM | DexCom, Inc. | 22.67B | -3.93% | 3,015,153 | 4.82B |
| 60 | ILMN | Illumina, Inc. | 21.84B | -0.91% | 901,684 | 4.39B |
| 61 | WST | West Pharmaceutical Services, Inc. | 21.45B | -2.71% | 265,426 | 3.22B |
| 62 | MTD | Mettler-Toledo International Inc. | 21.15B | -2.39% | 110,350 | 4.09B |
| 63 | LH | Labcorp Holdings Inc. | 21.02B | -0.40% | 185,759 | 14.14B |
| 64 | DGX | Quest Diagnostics Incorporated | 21.00B | -0.23% | 230,662 | 11.28B |
| 65 | ROIV | Roivant Sciences Ltd. | 20.97B | -0.32% | 1,860,906 | 13.31M |
| 66 | STE | STERIS plc | 20.68B | 0.01% | 374,448 | 5.94B |
| 67 | VTRS | Viatris Inc. | 20.16B | 0.82% | 4,751,541 | 14.56B |
| 68 | MRNA | Moderna, Inc. | 20.03B | -5.26% | 4,509,236 | 2.23B |
| 69 | INCY | Incyte Corporation | 19.62B | -0.93% | 612,408 | 5.36B |
| 70 | THC | Tenet Healthcare Corporation | 16.95B | 0.47% | 344,138 | 21.46B |
| 71 | GMAB | Genmab A/S | 16.50B | -1.96% | 1,041,467 | 3.90B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.24B | 0.66% | 1,001,988 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 16.11B | 2.83% | 668,088 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 15.26B | 3.38% | 230,316 | 998.25M |
| 75 | SMMT | Summit Therapeutics Inc. | 14.55B | -1.11% | 984,262 | - |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.42B | 0.89% | 435,773 | 4.44B |
| 77 | RGC | Regencell Bioscience Holdings Limited | 13.79B | 5.81% | 59,622 | - |
| 78 | BBIO | BridgeBio Pharma, Inc. | 13.68B | 5.91% | 1,632,402 | 579.96M |
| 79 | SOLV | Solventum Corporation | 12.89B | -0.91% | 981,935 | 8.26B |
| 80 | GH | Guardant Health, Inc. | 12.88B | -2.79% | 631,945 | 1.08B |
| 81 | SNN | Smith & Nephew plc | 12.72B | -0.50% | 793,777 | 6.16B |
| 82 | DVA | DaVita Inc. | 12.71B | -1.32% | 236,640 | 13.84B |
| 83 | PEN | Penumbra, Inc. | 12.70B | 0.04% | 104,318 | 1.45B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.70B | 1.35% | 404,438 | 1.06B |
| 85 | EXEL | Exelixis, Inc. | 12.62B | 1.50% | 1,154,035 | 2.38B |
| 86 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.05B | 2.47% | 229,330 | 1.13B |
| 87 | MEDP | Medpace Holdings, Inc. | 11.99B | -0.01% | 285,861 | 2.68B |
| 88 | AXSM | Axsome Therapeutics, Inc. | 11.94B | 3.58% | 272,105 | 708.24M |
| 89 | COO | The Cooper Companies, Inc. | 11.66B | -0.32% | 760,712 | 4.15B |
| 90 | BTSG | BrightSpring Health Services, Inc. | 11.65B | 2.09% | 1,138,795 | 13.65B |
| 91 | ALGN | Align Technology, Inc. | 11.62B | -2.17% | 213,491 | 4.10B |
| 92 | FMS | Fresenius Medical Care AG | 11.49B | -4.00% | 605,909 | 22.32B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.00B | 3.41% | 2,719,038 | 3.58B |
| 94 | ELAN | Elanco Animal Health Incorporated | 10.92B | 2.05% | 2,650,402 | 4.89B |
| 95 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.91B | -2.00% | 777,047 | 622.01M |
| 96 | RVTY | Revvity, Inc. | 10.80B | -2.70% | 351,289 | 2.90B |
| 97 | EHC | Encompass Health Corporation | 10.72B | -0.06% | 300,001 | 6.07B |
| 98 | GMED | Globus Medical, Inc. | 10.39B | 0.53% | 560,806 | 3.10B |
| 99 | UHS | Universal Health Services, Inc. | 10.36B | 0.91% | 374,554 | 17.76B |
| 100 | ENSG | The Ensign Group, Inc. | 10.28B | 0.72% | 284,030 | 5.27B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.26B | 0.42% | 853,717 | 3.24B |
| 102 | PODD | Insulet Corporation | 10.23B | -6.73% | 665,744 | 2.90B |
| 103 | MOH | Molina Healthcare, Inc. | 9.98B | - | 207,462 | 43.10B |
| 104 | ABVX | ABIVAX Société Anonyme | 9.63B | 0.26% | 494,751 | 5.37M |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 9.45B | -1.28% | 188,590 | 7.46M |
| 106 | CYTK | Cytokinetics, Incorporated | 9.42B | 1.24% | 709,280 | 105.82M |
| 107 | MASI | Masimo Corporation | 9.35B | -0.04% | 285,998 | 1.56B |
| 108 | KRYS | Krystal Biotech, Inc. | 9.23B | 0.86% | 142,214 | 417.30M |
| 109 | BAX | Baxter International Inc. | 9.09B | -1.62% | 2,376,891 | 11.32B |
| 110 | ICLR | ICON Public Limited Company | 8.85B | -4.93% | 258,473 | 8.10B |
| 111 | IBRX | ImmunityBio, Inc. | 8.56B | 0.62% | 6,066,128 | 140.98M |
| 112 | TEM | Tempus AI, Inc. | 8.25B | -2.15% | 3,359,638 | 1.36B |
| 113 | NUVL | Nuvalent, Inc. | 8.13B | 0.40% | 120,239 | - |
| 114 | HALO | Halozyme Therapeutics, Inc. | 8.09B | -3.81% | 1,280,201 | 1.51B |
| 115 | GKOS | Glaukos Corporation | 8.04B | 0.41% | 126,896 | 551.35M |
| 116 | HSIC | Henry Schein, Inc. | 7.89B | -0.19% | 633,481 | 13.38B |
| 117 | PCVX | Vaxcyte, Inc. | 7.88B | 0.98% | 678,074 | - |
| 118 | CRL | Charles River Laboratories International, Inc. | 7.71B | -5.06% | 253,464 | 4.03B |
| 119 | ATR | AptarGroup, Inc. | 7.48B | -0.71% | 316,616 | 3.87B |
| 120 | OSCR | Oscar Health, Inc. | 7.19B | 0.63% | 6,580,145 | 13.30B |
| 121 | KYMR | Kymera Therapeutics, Inc. | 6.96B | 1.23% | 96,700 | 51.48M |
| 122 | TECH | Bio-Techne Corporation | 6.93B | -6.68% | 1,550,493 | 1.21B |
| 123 | HQY | HealthEquity, Inc. | 6.92B | 1.75% | 702,488 | 1.31B |
| 124 | QGEN | Qiagen N.V. | 6.85B | -1.69% | 1,699,434 | 2.10B |
| 125 | MIRM | Mirum Pharmaceuticals, Inc. | 6.74B | 3.39% | 4,625,072 | 569.61M |
| 126 | BRKR | Bruker Corporation | 6.74B | -1.07% | 4,664,980 | 3.46B |
| 127 | SYRE | Spyre Therapeutics, Inc. | 6.68B | 2.45% | 251,372 | - |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.57B | 2.18% | 193,102 | 74.06M |
| 129 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.56B | 4.77% | 635,381 | 217.17M |
| 130 | ALKS | Alkermes plc | 6.49B | 1.75% | 1,446,598 | 1.56B |
| 131 | BIO | Bio-Rad Laboratories, Inc. | 6.49B | 0.34% | 87,122 | 2.59B |
| 132 | PACS | PACS Group, Inc. | 6.49B | -0.05% | 928,447 | 5.43B |
| 133 | CGON | CG Oncology, Inc. | 6.36B | 0.04% | 208,215 | 5.07M |
| 134 | GRFS | Grifols, S.A. | 6.29B | 1.72% | 508,437 | 8.58B |
| 135 | LNTH | Lantheus Holdings, Inc. | 6.24B | -0.33% | 415,512 | 1.55B |
| 136 | APGE | Apogee Therapeutics, Inc. | 6.15B | -0.98% | 138,203 | - |
| 137 | CNTA | Centessa Pharmaceuticals plc | 6.12B | -0.06% | 1,393,101 | 15.00M |
| 138 | BLTE | Belite Bio, Inc | 6.11B | -0.12% | 75,775 | - |
| 139 | RGEN | Repligen Corporation | 6.11B | -4.64% | 834,098 | 763.34M |
| 140 | CORT | Corcept Therapeutics Incorporated | 6.06B | 10.28% | 856,564 | 769.10M |
| 141 | PTCT | PTC Therapeutics, Inc. | 6.03B | -3.03% | 537,672 | 827.11M |
| 142 | TGTX | TG Therapeutics, Inc. | 6.00B | -0.54% | 687,977 | 700.35M |
| 143 | SRRK | Scholar Rock Holding Corporation | 5.99B | 1.55% | 566,179 | - |
| 144 | IMVT | Immunovant, Inc. | 5.91B | 1.43% | 493,129 | - |
| 145 | CELC | Celcuity Inc. | 5.91B | -1.95% | 322,243 | - |
| 146 | COGT | Cogent Biosciences, Inc. | 5.84B | -1.07% | 424,591 | - |
| 147 | TFX | Teleflex Incorporated | 5.79B | 1.29% | 319,038 | 2.13B |
| 148 | BLCO | Bausch + Lomb Corporation | 5.77B | 1.00% | 325,600 | 5.21B |
| 149 | HIMS | Hims & Hers Health, Inc. | 5.61B | -3.20% | 18,160,397 | 2.37B |
| 150 | CHE | Chemed Corporation | 5.54B | -0.09% | 184,975 | 2.54B |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 5.36B | 0.84% | 405,265 | 7.50M |
| 152 | AVTR | Avantor, Inc. | 5.36B | -3.98% | 3,098,768 | 6.55B |
| 153 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | -0.05% | 5,631,181 | 1.11B |
| 154 | LEGN | Legend Biotech Corporation | 5.24B | 0.28% | 1,439,115 | 1.14B |
| 155 | CRSP | CRISPR Therapeutics AG | 5.13B | 0.72% | 459,943 | 4.10M |
| 156 | LQDA | Liquidia Corporation | 5.01B | -0.41% | 1,160,110 | 288.07M |
| 157 | STVN | Stevanato Group S.p.A. | 4.90B | -1.64% | 151,372 | 1.39B |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 4.60B | -2.28% | 174,959 | 1.34M |
| 159 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.59B | 0.40% | 142,208 | 754.05M |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 4.46B | 0.22% | 93,726 | 274.48M |
| 161 | MANE | Veradermics, Incorporated | 4.44B | 3.85% | 133,913 | - |
| 162 | SHC | Sotera Health Company | 4.41B | -1.09% | 2,939,341 | 1.19B |
| 163 | DOCS | Doximity, Inc. | 4.34B | -11.08% | 5,255,142 | 637.78M |
| 164 | NAMS | NewAmsterdam Pharma Company N.V. | 4.30B | -3.73% | 924,312 | 22.57M |
| 165 | BLLN | BillionToOne, Inc. | 4.23B | -2.30% | 210,421 | 354.54M |
| 166 | RDNT | RadNet, Inc. | 4.22B | -4.13% | 345,478 | 2.14B |
| 167 | HNGE | Hinge Health, Inc. | 4.19B | -1.96% | 637,749 | 646.34M |
| 168 | TVTX | Travere Therapeutics, Inc. | 4.13B | 3.55% | 859,661 | 536.20M |
| 169 | CAI | Caris Life Sciences, Inc. | 4.10B | -13.51% | 4,085,360 | 907.29M |
| 170 | AMRX | Amneal Pharmaceuticals, Inc. | 4.01B | -0.24% | 367,947 | 3.05B |
| 171 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.99B | 2.41% | 464,183 | 18.07M |
| 172 | LIVN | LivaNova PLC | 3.96B | 0.50% | 170,777 | 1.43B |
| 173 | NVST | Envista Holdings Corporation | 3.88B | -1.69% | 1,011,204 | 2.81B |
| 174 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | 0.10% | 1,593,174 | 596.96M |
| 175 | ORKA | Oruka Therapeutics, Inc. | 3.80B | -1.73% | 385,765 | - |
| 176 | ALHC | Alignment Healthcare, Inc. | 3.78B | -0.54% | 4,037,122 | 4.26B |
| 177 | IRTC | iRhythm Holdings, Inc. | 3.76B | -3.28% | 102,380 | 787.85M |
| 178 | MMSI | Merit Medical Systems, Inc. | 3.75B | 2.76% | 424,375 | 1.54B |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 3.73B | 0.41% | 459,114 | 1.10B |
| 180 | VKTX | Viking Therapeutics, Inc. | 3.66B | 0.64% | 432,424 | - |
| 181 | WAY | Waystar Holding Corp. | 3.60B | -3.15% | 911,056 | 1.16B |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.59B | -1.85% | 437,869 | - |
| 183 | TNGX | Tango Therapeutics, Inc. | 3.57B | 5.40% | 1,536,555 | 62.38M |
| 184 | TLX | Telix Pharmaceuticals Limited | 3.55B | 1.15% | 37,156 | 803.79M |
| 185 | OGN | Organon & Co. | 3.50B | 0.26% | 2,435,068 | 6.16B |
| 186 | WRBY | Warby Parker Inc. | 3.45B | 4.30% | 1,597,458 | 890.57M |
| 187 | TWST | Twist Bioscience Corporation | 3.43B | -1.52% | 532,186 | 409.48M |
| 188 | CON | Concentra Group Holdings Parent, Inc. | 3.28B | 0.35% | 417,658 | 2.23B |
| 189 | MMED | MiniMed Group, Inc. | 3.22B | -3.62% | 444,840 | 2.99B |
| 190 | BEAM | Beam Therapeutics Inc. | 3.20B | 1.87% | 489,234 | 164.01M |
| 191 | ERAS | Erasca, Inc. | 3.19B | -1.25% | 1,398,168 | - |
| 192 | RCUS | Arcus Biosciences, Inc. | 3.17B | 1.12% | 197,715 | 236.00M |
| 193 | LFST | LifeStance Health Group, Inc. | 3.13B | 1.70% | 2,307,765 | 1.49B |
| 194 | OPCH | Option Care Health, Inc. | 3.12B | 1.28% | 2,617,965 | 5.67B |
| 195 | DNLI | Denali Therapeutics Inc. | 3.11B | 0.72% | 402,219 | - |
| 196 | BKD | Brookdale Senior Living Inc. | 3.09B | -0.23% | 1,553,973 | 3.00B |
| 197 | ALMS | Alumis Inc. | 3.08B | 3.15% | 315,988 | 24.05M |
| 198 | ICUI | ICU Medical, Inc. | 3.05B | -0.86% | 115,081 | 2.16B |
| 199 | ITGR | Integer Holdings Corporation | 3.05B | 5.61% | 335,890 | 1.86B |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.05B | 0.27% | 286,403 | - |
| 201 | VCYT | Veracyte, Inc. | 3.03B | -4.15% | 397,815 | 541.74M |
| 202 | NHC | National HealthCare Corporation | 2.99B | 1.20% | 39,962 | 1.53B |
| 203 | SUPN | Supernus Pharmaceuticals, Inc. | 2.95B | 0.47% | 131,029 | 776.83M |
| 204 | KLRA | Kailera Therapeutics, Inc. | 2.88B | -0.38% | 124,433 | - |
| 205 | PRVA | Privia Health Group, Inc. | 2.84B | -2.04% | 358,055 | 2.25B |
| 206 | TARS | Tarsus Pharmaceuticals, Inc. | 2.76B | 7.26% | 486,930 | 535.08M |
| 207 | SLNO | Soleno Therapeutics, Inc. | 2.76B | 0.03% | 740,352 | 285.01M |
| 208 | VERA | Vera Therapeutics, Inc. | 2.74B | 3.95% | 277,149 | - |
| 209 | ARQT | Arcutis Biotherapeutics, Inc. | 2.69B | 3.91% | 1,912,173 | 415.62M |
| 210 | GPCR | Structure Therapeutics Inc. | 2.68B | -0.26% | 227,285 | - |
| 211 | ELVN | Enliven Therapeutics, Inc. | 2.68B | 3.88% | 607,484 | - |
| 212 | HTFL | HeartFlow, Inc. | 2.66B | 4.86% | 350,329 | 176.03M |
| 213 | IRON | Disc Medicine, Inc. | 2.66B | 1.53% | 343,200 | - |
| 214 | GRAL | GRAIL, Inc. | 2.61B | -1.69% | 216,833 | 156.12M |
| 215 | TXG | 10x Genomics, Inc. | 2.59B | -2.29% | 646,029 | 638.78M |
| 216 | RARE | Ultragenyx Pharmaceutical Inc. | 2.59B | -1.68% | 342,738 | 670.00M |
| 217 | NKTR | Nektar Therapeutics | 2.59B | -2.26% | 314,973 | 55.63M |
| 218 | HAE | Haemonetics Corporation | 2.57B | 2.28% | 305,737 | 1.33B |
| 219 | CLDX | Celldex Therapeutics, Inc. | 2.56B | 1.97% | 461,784 | 865.00K |
| 220 | IMNM | Immunome, Inc. | 2.53B | -1.41% | 446,634 | 4.02M |
| 221 | ACHC | Acadia Healthcare Company, Inc. | 2.53B | 5.61% | 1,650,122 | 3.37B |
| 222 | IDYA | IDEAYA Biosciences, Inc. | 2.51B | 1.49% | 360,114 | 225.27M |
| 223 | RLAY | Relay Therapeutics, Inc. | 2.48B | 0.15% | 615,419 | 10.68M |
| 224 | PBH | Prestige Consumer Healthcare Inc. | 2.46B | 2.96% | 245,883 | 1.10B |
| 225 | KOD | Kodiak Sciences Inc. | 2.45B | -0.47% | 152,534 | - |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.42B | 8.41% | 9,670,871 | 885.72M |
| 227 | DFTX | Definium Therapeutics, Inc. | 2.42B | 4.82% | 576,813 | - |
| 228 | LMAT | LeMaitre Vascular, Inc. | 2.30B | 3.53% | 140,309 | 256.28M |
| 229 | NBTX | Nanobiotix S.A. | 2.29B | 7.40% | 39,904 | 38.27M |
| 230 | ZLAB | Zai Lab Limited | 2.26B | 3.17% | 343,078 | 453.28M |
| 231 | MLYS | Mineralys Therapeutics, Inc. | 2.25B | -6.73% | 900,778 | - |
| 232 | GRDN | Guardian Pharmacy Services, Inc. | 2.25B | 1.78% | 144,485 | 1.46B |
| 233 | TRVI | Trevi Therapeutics, Inc. | 2.22B | 6.03% | 808,905 | - |
| 234 | HCM | HUTCHMED (China) Limited | 2.19B | 0.16% | 9,083 | 548.51M |
| 235 | ASTH | Astrana Health, Inc. | 2.19B | 0.72% | 195,360 | 3.53B |
| 236 | AXGN | Axogen, Inc. | 2.16B | -0.95% | 302,892 | 238.11M |
| 237 | TMDX | TransMedics Group, Inc. | 2.14B | -3.18% | 1,458,963 | 635.89M |
| 238 | NVCR | NovoCure Limited | 2.13B | 0.55% | 410,375 | 674.41M |
| 239 | XRAY | DENTSPLY SIRONA Inc. | 2.13B | -3.32% | 1,702,976 | 3.68B |
| 240 | PHVS | Pharvaris N.V. | 2.13B | 4.16% | 52,124 | - |
| 241 | TYRA | Tyra Biosciences, Inc. | 2.13B | 2.52% | 209,426 | - |
| 242 | ADPT | Adaptive Biotechnologies Corporation | 2.11B | -3.37% | 347,498 | 295.41M |
| 243 | GENB | Generate Biomedicines, Inc. | 2.08B | 5.33% | 240,888 | 30.30M |
| 244 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | -0.44% | 642,056 | 298.30M |
| 245 | SEM | Select Medical Holdings Corporation | 2.04B | 0.06% | 817,415 | 5.52B |
| 246 | ESTA | Establishment Labs Holdings Inc. | 2.03B | -0.25% | 201,827 | 229.58M |
| 247 | SRPT | Sarepta Therapeutics, Inc. | 2.02B | 0.26% | 1,105,568 | 2.18B |
| 248 | OCUL | Ocular Therapeutix, Inc. | 2.02B | 0.87% | 1,347,143 | 52.04M |
| 249 | BHC | Bausch Health Companies Inc. | 1.98B | -2.03% | 763,831 | 10.53B |
| 250 | NTLA | Intellia Therapeutics, Inc. | 1.98B | 1.22% | 2,186,279 | 66.09M |
| 251 | OMCL | Omnicell, Inc. | 1.96B | -1.35% | 285,374 | 1.23B |
| 252 | ADMA | ADMA Biologics, Inc. | 1.95B | - | 1,973,666 | 509.86M |
| 253 | STOK | Stoke Therapeutics, Inc. | 1.94B | -4.28% | 311,572 | 32.08M |
| 254 | AAPG | Ascentage Pharma Group International | 1.92B | -0.28% | 2,428 | 82.08M |
| 255 | CLOV | Clover Health Investments, Corp. | 1.91B | 10.67% | 9,006,056 | 2.21B |
| 256 | MD | Pediatrix Medical Group, Inc. | 1.91B | 0.51% | 386,882 | 1.93B |
| 257 | NEOG | Neogen Corporation | 1.90B | 1.39% | 841,720 | 870.56M |
| 258 | MESO | Mesoblast Limited | 1.90B | 1.94% | 73,926 | 65.38M |
| 259 | SION | Sionna Therapeutics, Inc. | 1.90B | 2.71% | 192,701 | - |
| 260 | TSHA | Taysha Gene Therapies, Inc. | 1.88B | -4.53% | 874,613 | 7.47M |
| 261 | ANAB | AnaptysBio, Inc. | 1.87B | -2.26% | 489,750 | 232.39M |
| 262 | LKFT | Lakefront Biotherapeutics NV | 1.86B | 3.00% | 118,092 | 1.20B |
| 263 | SNDX | Syndax Pharmaceuticals, Inc. | 1.86B | 2.65% | 551,119 | 217.17M |
| 264 | OCS | Oculis Holding AG | 1.84B | 2.40% | 514,636 | 1.40M |
| 265 | PGNY | Progyny, Inc. | 1.84B | 0.21% | 575,474 | 1.29B |
| 266 | SGRY | Surgery Partners, Inc. | 1.81B | 0.07% | 1,268,990 | 3.34B |
| 267 | RAPP | Rapport Therapeutics, Inc. | 1.80B | 1.09% | 93,850 | 20.00M |
| 268 | ZYME | Zymeworks Inc. | 1.80B | 3.05% | 317,782 | 81.26M |
| 269 | QURE | uniQure N.V. | 1.80B | -2.06% | 930,452 | 18.09M |
| 270 | SNDA | Sonida Senior Living, Inc. | 1.78B | 2.51% | 169,930 | 367.34M |
| 271 | HRMY | Harmony Biosciences Holdings, Inc. | 1.76B | 1.03% | 202,731 | 899.11M |
| 272 | MBX | MBX Biosciences, Inc. | 1.75B | -0.74% | 309,436 | - |
| 273 | VRDN | Viridian Therapeutics, Inc. | 1.74B | 0.36% | 905,613 | 70.92M |
| 274 | CAPR | Capricor Therapeutics, Inc. | 1.73B | -4.85% | 769,999 | 11.13M |
| 275 | PVLA | Palvella Therapeutics, Inc. | 1.73B | -4.09% | 78,210 | - |
| 276 | ADUS | Addus HomeCare Corporation | 1.73B | -3.98% | 210,961 | 1.45B |
| 277 | ANIP | ANI Pharmaceuticals, Inc. | 1.72B | 1.83% | 102,227 | 923.71M |
| 278 | INVA | Innoviva, Inc. | 1.70B | 1.54% | 289,767 | 420.69M |
| 279 | UFPT | UFP Technologies, Inc. | 1.70B | -0.54% | 117,721 | 608.85M |
| 280 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | 0.18% | 233,462 | 66.05M |
| 281 | NRIX | Nurix Therapeutics, Inc. | 1.69B | 2.26% | 304,103 | 71.78M |
| 282 | AHG | Akso Health Group | 1.68B | -7.33% | 183,443 | 14.84M |
| 283 | VCEL | Vericel Corporation | 1.67B | -0.49% | 211,856 | 292.09M |
| 284 | NUVB | Nuvation Bio Inc. | 1.65B | -2.27% | 2,044,835 | 143.05M |
| 285 | RXRX | Recursion Pharmaceuticals, Inc. | 1.64B | -1.90% | 6,650,168 | 66.41M |
| 286 | IOVA | Iovance Biotherapeutics, Inc. | 1.63B | 2.53% | 4,044,295 | 285.61M |
| 287 | PLSE | Pulse Biosciences, Inc. | 1.62B | 2.15% | 154,868 | 751.00K |
| 288 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.62B | 1.11% | 473,981 | -665.00K |
| 289 | INBX | Inhibrx Biosciences, Inc. | 1.61B | 1.69% | 267,473 | 1.30M |
| 290 | ALMR | Alamar Biosciences, Inc. | 1.61B | 3.00% | 109,729 | 74.21M |
| 291 | GLUE | Monte Rosa Therapeutics, Inc. | 1.60B | -1.05% | 227,040 | 42.95M |
| 292 | ARDX | Ardelyx, Inc. | 1.59B | -2.57% | 4,892,957 | 427.68M |
| 293 | PRCT | PROCEPT BioRobotics Corporation | 1.58B | -3.45% | 1,511,025 | 322.02M |
| 294 | VIR | Vir Biotechnology, Inc. | 1.56B | -1.49% | 378,445 | 65.50M |
| 295 | ATAI | AtaiBeckley Inc. | 1.56B | 2.53% | 2,504,237 | 3.49M |
| 296 | NVAX | Novavax, Inc. | 1.54B | -2.75% | 2,061,231 | 596.34M |
| 297 | PRGO | Perrigo Company plc | 1.51B | -2.16% | 746,468 | 4.18B |
| 298 | DMRA | Damora Therapeutics, Inc. | 1.48B | 6.65% | 276,022 | - |
| 299 | ENOV | Enovis Corporation | 1.48B | -1.12% | 266,035 | 2.28B |
| 300 | PGEN | Precigen, Inc. | 1.47B | 1.96% | 1,196,719 | 9.68M |
| 301 | PAHC | Phibro Animal Health Corporation | 1.46B | -1.45% | 149,513 | 1.50B |
| 302 | URGN | UroGen Pharma Ltd. | 1.46B | 0.54% | 424,140 | 140.49M |
| 303 | HCSG | Healthcare Services Group, Inc. | 1.46B | -3.98% | 215,513 | 1.85B |
| 304 | MAZE | Maze Therapeutics, Inc. | 1.46B | 2.21% | 434,723 | 20.00M |
| 305 | ABCL | AbCellera Biologics Inc. | 1.46B | -3.64% | 4,278,445 | 79.21M |
| 306 | IMCR | Immunocore Holdings plc | 1.45B | -2.41% | 48,783 | 412.81M |
| 307 | CMPS | COMPASS Pathways plc | 1.45B | 14.46% | 5,990,348 | - |
| 308 | AHCO | AdaptHealth Corp. | 1.45B | -3.38% | 624,785 | 3.29B |
| 309 | STAA | STAAR Surgical Company | 1.44B | 3.19% | 521,308 | 239.44M |
| 310 | AVAH | Aveanna Healthcare Holdings Inc. | 1.43B | -3.52% | 631,699 | 2.43B |
| 311 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.41% | 1,135,127 | 73.62M |
| 312 | IMTX | Immatics N.V. | 1.42B | -6.94% | 1,178,237 | 43.00M |
| 313 | ARDT | Ardent Health, Inc. | 1.41B | -2.09% | 120,616 | 6.43B |
| 314 | BCAX | Bicara Therapeutics Inc. | 1.41B | -4.40% | 411,534 | - |
| 315 | MPLT | MapLight Therapeutics, Inc. | 1.39B | 1.25% | 98,825 | - |
| 316 | GHRS | GH Research PLC | 1.36B | 1.60% | 63,515 | - |
| 317 | FTRE | Fortrea Holdings Inc. | 1.35B | -2.26% | 373,412 | 2.71B |
| 318 | BHVN | Biohaven Ltd. | 1.35B | -2.72% | 1,107,448 | - |
| 319 | ATRC | AtriCure, Inc. | 1.35B | -0.49% | 190,926 | 552.16M |
| 320 | AVBP | ArriVent BioPharma, Inc. | 1.34B | -0.72% | 121,528 | - |
| 321 | MLTX | MoonLake Immunotherapeutics | 1.34B | 0.77% | 545,611 | - |
| 322 | CRVS | Corvus Pharmaceuticals, Inc. | 1.33B | -0.75% | 642,441 | - |
| 323 | SVRA | Savara Inc. | 1.33B | 2.95% | 492,494 | - |
| 324 | WVE | Wave Life Sciences Ltd. | 1.33B | 1.47% | 3,302,070 | 71.80M |
| 325 | AVLN | Avalyn Pharma Inc. | 1.28B | 2.07% | 274,053 | - |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.27B | 1.25% | 105,695 | 83.72M |
| 327 | COAG | Hemab Therapeutics Holdings, Inc. | 1.25B | 9.07% | 118,784 | - |
| 328 | TDOC | Teladoc Health, Inc. | 1.23B | 0.89% | 1,277,359 | 2.51B |
| 329 | JBIO | Jade Biosciences, Inc. | 1.23B | -1.11% | 95,306 | - |
| 330 | INSP | Inspire Medical Systems, Inc. | 1.23B | -3.09% | 263,916 | 915.25M |
| 331 | PNTG | The Pennant Group, Inc. | 1.22B | -0.89% | 289,148 | 1.02B |
| 332 | DBVT | DBV Technologies S.A. | 1.21B | -1.75% | 78,670 | 5.74M |
| 333 | IVA | Inventiva S.A. | 1.20B | -2.17% | 32,593 | 7.94M |
| 334 | AGL | agilon health, inc. | 1.20B | 3.02% | 317,265 | 5.82B |
| 335 | ZBIO | Zenas BioPharma, Inc. | 1.19B | 4.65% | 208,660 | 10.00M |
| 336 | OLMA | Olema Pharmaceuticals, Inc. | 1.19B | -2.68% | 518,777 | - |
| 337 | ATEC | Alphatec Holdings, Inc. | 1.18B | -1.10% | 1,649,158 | 787.08M |
| 338 | WGS | GeneDx Holdings Corp. | 1.17B | -0.35% | 448,965 | 442.68M |
| 339 | AMN | AMN Healthcare Services, Inc. | 1.16B | 1.87% | 443,591 | 3.42B |
| 340 | AVNS | Avanos Medical, Inc. | 1.16B | 0.04% | 225,677 | 715.90M |
| 341 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.16B | -3.76% | 799,780 | 204.73M |
| 342 | ALVO | Alvotech | 1.14B | 2.82% | 368,623 | 562.04M |
| 343 | COLL | Collegium Pharmaceutical, Inc. | 1.14B | -1.65% | 259,447 | 796.33M |
| 344 | EYPT | EyePoint, Inc. | 1.14B | -0.37% | 320,476 | 7.61M |
| 345 | IART | Integra LifeSciences Holdings Corporation | 1.14B | 6.17% | 410,711 | 1.64B |
| 346 | HROW | Harrow, Inc. | 1.12B | 3.89% | 1,080,629 | 268.68M |
| 347 | SLS | SELLAS Life Sciences Group, Inc. | 1.12B | 15.71% | 18,082,580 | - |
| 348 | SEPN | Septerna, Inc. | 1.12B | -0.40% | 109,636 | 72.26M |
| 349 | XERS | Xeris Biopharma Holdings, Inc. | 1.11B | 2.56% | 916,998 | 314.85M |
| 350 | NNNN | Anbio Biotechnology | 1.10B | -2.85% | 6,418 | 8.65M |
| 351 | IRMD | IRADIMED CORPORATION | 1.09B | 0.99% | 34,268 | 86.28M |
| 352 | AORT | Artivion, Inc. | 1.09B | -2.60% | 362,239 | 458.69M |
| 353 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.08B | 1.24% | 2,394,106 | 69.64M |
| 354 | NEO | NeoGenomics, Inc. | 1.08B | -5.37% | 540,177 | 745.97M |
| 355 | CNMD | CONMED Corporation | 1.08B | -0.54% | 74,827 | 1.37B |
| 356 | BFLY | Butterfly Network, Inc. | 1.07B | -1.32% | 2,040,095 | 102.92M |
| 357 | AKTS | Aktis Oncology, Inc. | 1.07B | -2.05% | 50,903 | 8.28M |
| 358 | OMER | Omeros Corporation | 1.06B | -0.07% | 1,227,365 | - |
| 359 | CDNA | CareDx, Inc. | 1.06B | -3.74% | 143,433 | 412.82M |
| 360 | EVO | Evotec SE | 1.06B | -9.83% | 125,916 | 859.03M |
| 361 | CRON | Cronos Group Inc. | 1.04B | -0.36% | 805,009 | 159.54M |
| 362 | BLFS | BioLife Solutions, Inc. | 1.02B | -1.91% | 110,712 | 101.66M |
| 363 | INNV | InnovAge Holding Corp. | 1.00B | -2.25% | 143,923 | 949.17M |
| 364 | PHAT | Phathom Pharmaceuticals, Inc. | 999.23M | 0.40% | 470,314 | 204.89M |
| 365 | MNKD | MannKind Corporation | 993.27M | -1.98% | 1,831,202 | 360.78M |
| 366 | CGEM | Cullinan Therapeutics, Inc. | 978.41M | -1.42% | 459,358 | - |
| 367 | TNDM | Tandem Diabetes Care, Inc. | 975.17M | -3.13% | 858,121 | 1.03B |
| 368 | DSGN | Design Therapeutics, Inc. | 974.95M | -1.14% | 260,796 | - |
| 369 | OMDA | Omada Health, Inc. | 945.53M | 6.67% | 1,780,583 | 283.30M |
| 370 | SDGR | Schrödinger, Inc. | 944.47M | -0.39% | 373,012 | 254.91M |
| 371 | PHAR | Pharming Group N.V. | 940.29M | 0.92% | 6,094 | 369.49M |
| 372 | MGTX | MeiraGTx Holdings plc | 934.99M | 3.17% | 140,216 | 81.39M |
| 373 | USPH | U.S. Physical Therapy, Inc. | 925.76M | -0.03% | 112,981 | 787.69M |
| 374 | LBRX | LB Pharmaceuticals Inc | 922.21M | 3.31% | 60,082 | - |
| 375 | GERN | Geron Corporation | 920.58M | 2.50% | 14,526,410 | 196.12M |
| 376 | NUTX | Nutex Health Inc. | 919.76M | -1.34% | 64,860 | 879.95M |
| 377 | XNCR | Xencor, Inc. | 912.68M | -1.05% | 232,741 | 97.36M |
| 378 | PCRX | Pacira BioSciences, Inc. | 900.28M | 0.18% | 117,792 | 734.86M |
| 379 | ANNX | Annexon, Inc. | 892.12M | 0.09% | 864,192 | - |
| 380 | GDRX | GoodRx Holdings, Inc. | 890.72M | -2.23% | 507,874 | 787.89M |
| 381 | ORIC | ORIC Pharmaceuticals, Inc. | 888.18M | -2.83% | 422,203 | - |
| 382 | INMD | InMode Ltd. | 884.49M | 0.94% | 613,204 | 374.64M |
| 383 | JANX | Janux Therapeutics, Inc. | 880.61M | 0.21% | 350,229 | 13.73M |
| 384 | SPTX | Seaport Therapeutics, Inc. | 874.96M | 3.45% | 239,066 | - |
| 385 | TALK | Talkspace, Inc. | 868.55M | 0.10% | 667,744 | 238.37M |
| 386 | VOR | Vor Biopharma Inc. | 868.06M | -2.73% | 378,656 | - |
| 387 | BVS | Bioventus Inc. | 865.42M | 2.17% | 134,339 | 576.30M |
| 388 | SANA | Sana Biotechnology, Inc. | 864.10M | -4.75% | 1,714,684 | - |
| 389 | TBPH | Theravance Biopharma, Inc. | 860.94M | 1.33% | 132,129 | 109.78M |
| 390 | ABSI | Absci Corporation | 857.48M | 2.71% | 1,712,783 | 1.84M |
| 391 | ABUS | Arbutus Biopharma Corporation | 849.79M | 0.12% | 756,762 | 191.45M |
| 392 | SPRY | ARS Pharmaceuticals, Inc. | 846.04M | -1.27% | 708,444 | 84.28M |
| 393 | ODTX | Odyssey Therapeutics, Inc. | 844.18M | -0.03% | 50,394 | 2.98M |
| 394 | KURA | Kura Oncology, Inc. | 842.47M | -1.96% | 1,159,485 | 71.64M |
| 395 | DRTS | Alpha Tau Medical Ltd. | 841.81M | -3.19% | 484,423 | - |
| 396 | BIOA | BioAge Labs, Inc. | 839.27M | 3.79% | 299,641 | 10.32M |
| 397 | ETON | Eton Pharmaceuticals, Inc. | 831.74M | 2.32% | 115,352 | 79.95M |
| 398 | OPK | OPKO Health, Inc. | 830.60M | - | 1,062,370 | 581.12M |
| 399 | EVMN | Evommune, Inc. | 823.74M | 0.79% | 109,688 | 10.00M |
| 400 | AURA | Aura Biosciences, Inc. | 815.72M | -0.50% | 218,175 | - |
| 401 | CTMX | CytomX Therapeutics, Inc. | 812.03M | -3.87% | 1,286,901 | 35.54M |
| 402 | SSII | SS Innovations International, Inc. | 811.76M | -1.22% | 47,967 | 42.48M |
| 403 | AMPH | Amphastar Pharmaceuticals, Inc. | 805.58M | 4.40% | 471,139 | 720.53M |
| 404 | ESPR | Esperion Therapeutics, Inc. | 804.47M | -0.16% | 7,663,321 | 418.24M |
| 405 | ANRO | Alto Neuroscience, Inc. | 803.93M | -6.88% | 239,451 | - |
| 406 | DRUG | Bright Minds Biosciences Inc. | 803.33M | 1.59% | 76,149 | - |
| 407 | LMRI | Lumexa Imaging Holdings, Inc. | 797.47M | -20.95% | 1,555,512 | 1.03B |
| 408 | SGP | SpyGlass Pharma, Inc. | 790.54M | -2.03% | 8,112 | - |
| 409 | AZTA | Azenta, Inc. | 785.88M | -2.74% | 480,303 | 596.48M |
| 410 | ALLO | Allogene Therapeutics, Inc. | 781.48M | -1.52% | 3,036,107 | 22.00K |
| 411 | RLMD | Relmada Therapeutics, Inc. | 766.73M | -1.88% | 615,667 | - |
| 412 | CERT | Certara, Inc. | 759.16M | -4.13% | 2,217,186 | 419.75M |
| 413 | QDEL | QuidelOrtho Corporation | 757.60M | -0.09% | 911,610 | 2.66B |
| 414 | SLDB | Solid Biosciences Inc. | 713.76M | -6.09% | 768,390 | - |
| 415 | TENX | Tenax Therapeutics, Inc. | 707.42M | -1.27% | 229,283 | - |
| 416 | EHAB | Enhabit, Inc. | 706.14M | -0.04% | 2,719,455 | 1.06B |
| 417 | ACRS | Aclaris Therapeutics, Inc. | 700.41M | 2.77% | 979,138 | 8.37M |
| 418 | BWAY | BrainsWay Ltd. | 673.90M | -4.42% | 291,039 | 52.23M |
| 419 | PSNL | Personalis, Inc. | 672.31M | 6.29% | 3,951,729 | 64.52M |
| 420 | HSTM | HealthStream, Inc. | 666.40M | -2.35% | 98,555 | 311.78M |
| 421 | CBLL | CeriBell, Inc. | 663.15M | 4.54% | 364,977 | 95.07M |
| 422 | ZVRA | Zevra Therapeutics, Inc. | 662.09M | 1.36% | 494,183 | 122.29M |
| 423 | GYRE | Gyre Therapeutics, Inc. | 661.53M | -0.82% | 20,744 | 117.05M |
| 424 | EIKN | Eikon Therapeutics, Inc. | 658.32M | 5.46% | 207,403 | - |
| 425 | AVR | Anteris Technologies Global Corp. | 656.06M | -2.54% | 222,967 | 1.85M |
| 426 | TLRY | Tilray Brands, Inc. | 652.48M | 1.11% | 2,071,259 | 858.28M |
| 427 | KYTX | Kyverna Therapeutics, Inc. | 647.07M | 4.50% | 1,125,724 | - |
| 428 | SIBN | SI-BONE, Inc. | 641.73M | 4.10% | 865,791 | 206.22M |
| 429 | CADL | Candel Therapeutics, Inc. | 640.02M | 0.17% | 950,937 | - |
| 430 | STRO | Sutro Biopharma, Inc. | 638.03M | -5.87% | 119,218 | 102.48M |
| 431 | ARVN | Arvinas, Inc. | 628.44M | 1.78% | 364,123 | 89.40M |
| 432 | TRAX | First Tracks Biotherapeutics, Inc. | 626.87M | 1.29% | 107,423 | - |
| 433 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 625.86M | -3.81% | 125,584 | - |
| 434 | CBIO | Crescent Biopharma, Inc. | 624.71M | 1.84% | 62,354 | 11.88M |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 622.24M | -7.58% | 2,927,695 | 361.51M |
| 436 | FBRX | Forte Biosciences, Inc. | 619.58M | 0.58% | 69,834 | - |
| 437 | CRMD | CorMedix Inc. | 596.16M | 1.20% | 529,816 | 311.71M |
| 438 | PRME | Prime Medicine, Inc. | 594.23M | -0.30% | 1,127,946 | 4.03M |
| 439 | RIGL | Rigel Pharmaceuticals, Inc. | 592.07M | 8.95% | 496,874 | 299.77M |
| 440 | ALT | Altimmune, Inc. | 584.54M | -2.27% | 1,930,679 | 36.00K |
| 441 | CABA | Cabaletta Bio, Inc. | 573.94M | -3.03% | 3,359,141 | - |
| 442 | VALN | Valneva SE | 562.56M | 1.50% | 26,253 | 205.07M |
| 443 | IMMX | Immix Biopharma, Inc. | 559.81M | -0.94% | 313,489 | - |
| 444 | DNA | Ginkgo Bioworks Holdings, Inc. | 553.30M | 1.56% | 622,667 | 151.40M |
| 445 | AGMB | AgomAb Therapeutics NV | 551.58M | -7.28% | 25,115 | - |
| 446 | CSTL | Castle Biosciences, Inc. | 551.40M | -2.42% | 223,925 | 339.92M |
| 447 | PHR | Phreesia, Inc. | 551.12M | -5.62% | 419,938 | 480.59M |
| 448 | FDMT | 4D Molecular Therapeutics, Inc. | 543.93M | 0.63% | 140,595 | 88.24M |
| 449 | ANL | Adlai Nortye Ltd. | 541.20M | 2.89% | 15,430 | 5.00M |
| 450 | CLYM | Climb Bio, Inc. | 533.57M | - | 228,188 | - |
| 451 | PROK | ProKidney Corp. | 531.45M | -1.12% | 311,088 | 893.00K |
| 452 | MDXG | MiMedx Group, Inc. | 528.01M | 0.14% | 754,017 | 389.42M |
| 453 | AVTX | Avalo Therapeutics, Inc. | 527.61M | -0.95% | 636,210 | 59.00K |
| 454 | TECX | Tectonic Therapeutic, Inc. | 526.64M | -0.18% | 110,719 | - |
| 455 | XOMA | XOMA Royalty Corporation | 524.97M | 0.26% | 39,479 | 48.56M |
| 456 | TCMD | Tactile Systems Technology, Inc. | 524.66M | -1.15% | 214,742 | 343.52M |
| 457 | CTNM | Contineum Therapeutics, Inc. | 523.41M | 2.49% | 35,699 | - |
| 458 | CERS | Cerus Corporation | 518.96M | 1.57% | 993,423 | 216.56M |
| 459 | AQST | Aquestive Therapeutics, Inc. | 517.02M | - | 1,072,092 | 44.55M |
| 460 | RGNX | REGENXBIO Inc. | 516.17M | -2.34% | 1,127,663 | 170.44M |
| 461 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 462 | NPCE | NeuroPace, Inc. | 500.50M | -7.09% | 180,086 | 99.53M |
| 463 | PRTA | Prothena Corporation plc | 499.97M | 1.27% | 144,834 | 57.94M |
| 464 | STTK | Shattuck Labs, Inc. | 498.84M | -0.30% | 136,768 | 1.00M |
| 465 | NGNE | Neurogene Inc. | 498.00M | -0.08% | 64,707 | 925.00K |
| 466 | ASMB | Assembly Biosciences, Inc. | 496.96M | 1.46% | 22,129 | 71.10M |
| 467 | OCGN | Ocugen, Inc. | 495.93M | -0.34% | 1,894,207 | 4.47M |
| 468 | OFIX | Orthofix Medical Inc. | 494.36M | 0.41% | 89,907 | 825.37M |
| 469 | CTKB | Cytek Biosciences, Inc. | 488.80M | -6.31% | 975,247 | 204.17M |
| 470 | OVID | Ovid Therapeutics Inc. | 484.50M | -2.44% | 1,171,608 | 7.12M |
| 471 | UPB | Upstream Bio, Inc. | 483.25M | -0.78% | 184,372 | 3.32M |
| 472 | SRTA | Strata Critical Medical, Inc. | 471.57M | -0.37% | 693,131 | 228.58M |
| 473 | EPRX | Eupraxia Pharmaceuticals Inc. | 471.07M | 0.13% | 48,851 | - |
| 474 | CTEV | Claritev Corporation | 468.81M | -3.61% | 65,795 | 978.76M |
| 475 | KIDS | OrthoPediatrics Corp. | 465.93M | 2.37% | 90,132 | 243.30M |
| 476 | EVH | Evolent Health, Inc. | 464.55M | -0.72% | 1,126,247 | 1.89B |
| 477 | FULC | Fulcrum Therapeutics, Inc. | 464.43M | 0.14% | 156,197 | 80.00M |
| 478 | SGMT | Sagimet Biosciences Inc. | 458.20M | -3.01% | 355,564 | - |
| 479 | AUTL | Autolus Therapeutics plc | 456.44M | 7.19% | 1,425,366 | 75.39M |
| 480 | LXEO | Lexeo Therapeutics, Inc. | 455.43M | 1.75% | 266,612 | - |
| 481 | ANGO | AngioDynamics, Inc. | 452.04M | -0.50% | 136,970 | 313.73M |
| 482 | FLGT | Fulgent Genetics, Inc. | 451.85M | 0.70% | 186,347 | 320.35M |
| 483 | KMDA | Kamada Ltd. | 449.94M | -7.83% | 125,477 | 180.46M |
| 484 | PRLD | Prelude Therapeutics Incorporated | 447.57M | -4.09% | 186,151 | 16.72M |
| 485 | ZURA | Zura Bio Limited | 445.46M | -1.16% | 104,024 | - |
| 486 | LYEL | Lyell Immunopharma, Inc. | 441.80M | -1.64% | 18,298 | 31.00K |
| 487 | ADCT | ADC Therapeutics SA | 438.81M | 0.58% | 578,092 | 79.18M |
| 488 | REPL | Replimune Group, Inc. | 436.81M | 29.34% | 10,764,254 | - |
| 489 | EOLS | Evolus, Inc. | 432.01M | 0.92% | 241,624 | 301.79M |
| 490 | EBS | Emergent BioSolutions Inc. | 430.83M | -1.76% | 217,580 | 676.80M |
| 491 | VREX | Varex Imaging Corporation | 430.74M | 3.55% | 273,202 | 857.50M |
| 492 | CATX | Perspective Therapeutics, Inc. | 425.96M | -0.93% | 323,388 | 618.00K |
| 493 | PRTC | PureTech Health plc | 424.75M | 0.75% | 6,737 | 4.66M |
| 494 | BBNX | Beta Bionics, Inc. | 424.23M | -3.05% | 282,943 | 110.24M |
| 495 | CCRN | Cross Country Healthcare, Inc. | 424.20M | - | 309,798 | 1.00B |
| 496 | NRC | NRC Health | 421.21M | -2.61% | 42,648 | 138.64M |
| 497 | LRMR | Larimar Therapeutics, Inc. | 420.73M | -1.94% | 355,687 | - |
| 498 | CGC | Canopy Growth Corporation | 419.06M | 1.38% | 3,079,944 | 203.04M |
| 499 | WEAV | Weave Communications, Inc. | 418.52M | -3.49% | 396,258 | 248.72M |
| 500 | TOI | The Oncology Institute, Inc. | 417.43M | 3.86% | 2,281,146 | 545.76M |